Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: A meta-analysis

Neurology

Volumn 72, Issue 7, 2009, Pages 635-642

  Van Der Bilt, I A C ^a   Hasan, D ^b   Vandertop, W P ^a   Wilde, A A M ^a   Algra, A ^c   Visser, F C ^d   Rinkel, G J E ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Academic Medical Center ^*  (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB; TROPONIN;

ARTICLE; BRADYCARDIA; BRAIN ISCHEMIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GLASGOW OUTCOME SCALE; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; Q WAVE; RANKIN SCALE; RISK FACTOR; ST SEGMENT DEPRESSION; SUBARACHNOID HEMORRHAGE; T WAVE; TACHYCARDIA; ADULT; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HEART DISEASE; MALE; META ANALYSIS; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; CLINICAL TRIALS AS TOPIC; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 61849183583     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000342471.07290.07     Document Type: Article

References (40)

1. Hop JW, Rinkel GJ, Algra A, Van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997;28:660-664.
2. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neu-rosurg 1968;28:14-20.
3. Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale. J Neurosurg 1988;68:985-986.
4. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974;2:81-84.
5. Botterell EH, Lougheed WM, Scott JW, Vanderwater SL. Hypothermia, and interruption of carotid, or carotid and vertebral circulation, in the surgical management of intra-cranial aneurysms. J Neurosurg 1956; 13:1-42.
6. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5. Chichester, UK: The Cochrane Collaboration; 2005.
7. Fabinyi G, Hunt D, McKinley L. Myocardial creatine ki-nase isoenzyme in serum after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1977;40:818-820.
8. Maiuri F, Benvenuti D, Carrieri P, Orefice G, Carbone M, Carandente M. Serum and cerebrospinal fluid enzymes in subarachnoid haemorrhage. Neurol Res 1989; 11:6-8.
9. Parekh N, Venkatesh B, Cross D, et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol 2000;36:1328-1335.
10. Wijdicks EF, Schievink WI, Burnett JC Jr. Natriuretic peptide system and endothelin in aneurysmal subarachnoid hemorrhage. J Neurosurg 1997;87:275-280.
11. Mayer SA, Lin J, Homma S, et al. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke 1999;30:780-786.
12. Sviri GE, Shik V, Raz B, Soustiel JF. Role of brain natriuretic peptide in cerebral vasospasm. Acta Neurochir (Wien) 2003;145:851-860.
13. Naidech AM, Kreiter KT, Janjua N, et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation 2005;112:2851-2856.
14. Schuiling WJ, Algra A, de Weerd AW, Leemans P, Rinkel GJ. ECG abnormalities in predicting secondary cerebral ischemia after subarachnoid haemorrhage. Acta Neurochir (Wien) 2006;148:853-858.
15. Yarlagadda S, Rajendran P, Miss JC, et al. Cardiovascular predictors of in-patient mortality after subarachnoid hemorrhage. Neurocrit Care 2006;5:102-107.
16. Deibert E, Barzilai B, Braverman AC, et al. Clinical significance of elevated troponin I levels in patients with non-traumatic subarachnoid hemorrhage. J Neurosurg 2003; 98:741-746.
17. Walter P, Neil-Dwyer G, Cruickshank JM. Beneficial effects of adrenergic blockade in patients with subarachnoid haemorrhage. BMJ (Clin Res Ed) 1982;284:1661-1664.
18. Neil-Dwyer G, Walter P, Cruickshank JM. Beta-blockade benefits patients following a subarachnoid haemorrhage. Eur J Clin Pharmacol 1985;28 (suppl):25-29.
19. Cruickshank JM, Neil-Dwyer G, Degaute JP, et al. Reduction of stress/catecholamine-induced cardiac necrosis by beta 1-selective blockade. Lancet 1987;2:585-589.
20. Neil-Dwyer G, Cruickshank JM, Stratton C. Beta-blocker, plasma total creatine kinase and creatine kinase myocardial isoenzyme, and the prognosis of subarachnoid hemorrhage. Surg Neurol 1986;25:163-168.
21. Brilstra EH, Rinkel GJ, Algra A, Van Gijn J. Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology 2000;55: 1656-1660.
22. Rabinstein AA, Friedman JA, Weigand SD, et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004;35:1862-1866.
23. Hop JW, Rinkel GJ, Algra A, Van Gijn J. Initial loss of consciousness and risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 1999;30: 2268-2271.
24. Chang HS, Hongo K, Nakagawa H. Adverse effects of limited hypotensive anesthesia on the outcome of patients with subarachnoid hemorrhage. J Neurosurg 2000;92: 971-975.
25. Lang EW, Diehl RR, Mehdorn HM. Cerebral autoregula-tion testing after aneurysmal subarachnoid hemorrhage: the phase relationship between arterial blood pressure and cerebral blood flow velocity. Crit Care Med 2001;29:158-163.
26. Soehle M, Czosnyka M, Pickard JD, Kirkpatrick PJ. Continuous assessment of cerebral auto regulation in subarachnoid hemorrhage. Anesth Analg 2004;98:1133-1139.
27. Kawasaki T, Azuma A, Sawada T, et al. Electrocardio-graphic score as a predictor of mortality after subarachnoid hemorrhage. Circ J 2002;66:567-570.
28. Zaroff JG, Rordorf GA, Newell JB, Ogilvy CS, Levinson JR. Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities. Neurosur-gery 1999;44:34-39.
29. Sakr YL, Lim N, Amaral AC, et al. Relation of ECG changes to neurological outcome in patients with aneurysmal subarachnoid hemorrhage. Int J Cardiol 2004;96:369-373.
30. Schuiling WJ, Dennesen PJ, Tans JT, Kingma LM, Algra A, Rinkel GJ. Troponin I in predicting cardiac or pulmonary complications and outcome in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2005;76: 1565-1569.
31. Sarner M, Crawford MD. Ruptured intracranial aneu-rysm: clinical series. Lancet 1965;2:1251-1254.
32. Hunt D, McRae C, Zapf P. Electrocardiographic and serum enzyme change in subarachnoid hemorrhage. Am Heart J 1969;77:479-488.
33. Page A, Boulard G, Guerin J, Pouyanne H. Electrocardiographic abnormalities during meningeal hemorrhage [in French]. Nouv Presse Med 1976;5:1405-1408.
34. Kettunen P. Subarachnoid haemorrhage and acute heart injury. Clin Chim Acta 1983;134:123-127.
35. Melin J, Fogelholm R. Electrocardiographic findings in subarachnoid hemorrhage: a population study. Acta Med Scand 1983;213:5-8.
36. Pollick C, Cujec B, Parker S, Tator C. Left ventricular wall motion abnormalities in subarachnoid hemorrhage: an echo-cardiographic study. J Am Coll Cardiol 1988;12:600-605.
37. Lorsheyd A, Simmers TA, Robles De Medina EO. The relationship between electrocardiographic abnormalities and location of the intracranial aneurysm in subarachnoid hemorrhage. Pacing Clin Electrophysiol 2003;26:1722-1728.
38. Kopelnik A, Fisher L, Miss JC, et al. Prevalence and implications of diastolic dysfunction after subarachnoid hemorrhage. Neurocrit Care 2005;3:132-138.
39. Banki N, Kopelnik A, Tung P, et al. Prospective analysis of prevalence, distribution, and rate of recovery of left ventricular systolic dysfunction in patients with subarachnoid hemorrhage. J Neurosurg 2006;105: 15-20.
40. Kothavale A, Banki NM, Kopelnik A, et al. Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocrit Care 2006;4:199-205.